Evidence map›Paper›PMID 42204361›Full record

ArticleNature biotechnology2026

Scoring gene importance by interpreting single-cell foundation models.

Maxwell P Gold, Miguel Reyes, Nathaniel Diamant, Tony Kuo, Ehsan Hajiramezanali, Jane W Newburger, Mary Beth F Son, Pui Y Lee, Gabriele Scalia, Aicha BenTaieb and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maxwell P GoldComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.
Miguel ReyesgRED Research Biology, Genentech, South San Francisco, CA, USA.
Nathaniel DiamantComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.
Tony KuogRED Research Biology, Genentech, South San Francisco, CA, USA.
Ehsan HajiramezanaliComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.
Jane W NewburgerDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7794-9017
Mary Beth F SonDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Pui Y LeeDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Gabriele ScaliaComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-3305-9220
Aicha BenTaiebComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-7899-3327
Sharookh B KapadiagRED Research Biology, Genentech, South San Francisco, CA, USA.
Anupriya TripathiComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.
Héctor Corrada BravoComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA.
Graham HeimbergComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA. heimberg@gene.com.
Tommaso BiancalaniComputational Sciences Center of Excellence, Genentech, South San Francisco, CA, USA. tbiancalani@lila.ai.ORCID http://orcid.org/0000-0001-9104-9755

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining a gene's functional importance within a cellular context has long been a challenge, as absolute expression level is an unreliable indicator. Here we introduce SIGnature, a framework for scoring gene importance using attributions derived from single-cell RNA-sequencing (scRNA-seq) foundation models. Attribution scores reduce technical noise, emphasize regulatory genes and facilitate cross-dataset comparison-a core challenge for scRNA-seq analyses. We developed the SIGnature package as a tool for generating and querying attributions, enabling rapid gene set searches across large scRNA-seq atlases. We demonstrate its utility using the MS1 monocyte signature, a poorly understood gene program activated in severe COVID-19 and sepsis. Searching 400 studies identified associations between the MS1 signature and multiple hyperinflammatory conditions, including Kawasaki disease. Experimental validation confirmed that serum from persons with Kawasaki disease induces the MS1 phenotype. These findings highlight that SIGnature can uncover shared mechanisms across conditions, demonstrating its power for large-scale signature scoring and cross-disease analysis.

Identifiers

PMID42204361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.